Sun Pharmaceutical Industries Limited is one of India’s largest pharmaceutical companies. It is known for producing high-quality generic medicines and specialty drugs for various therapeutic areas.
About Sun Pharma
Sun Pharma is a leading global pharmaceutical company that provides medicines in over 100 countries. It has a strong presence in India, the US, and emerging markets with a focus on dermatology, ophthalmology, and chronic disease treatments.
Company Details
- Founded: 1983
- Headquarters: Mumbai, India
- Industry: Pharmaceuticals, Healthcare
- Market Cap: Over INR 3 lakh crore (as of 2024)
- Key Focus Areas: Specialty medicines, generics, active pharmaceutical ingredients (APIs)
Promoter
| Name | Stake Percentage |
|---|---|
| Dilip Shanghvi & Family | 54.48% |
| Public & Others | 45.52% |
Sun Pharma Share Price Target 2025
- Maximum Target: INR 1,700
- Minimum Target: INR 1,400
Sun Pharma is expected to perform well in 2025 due to its expanding specialty drug portfolio, strong US market presence, and increasing global demand for generics. The company continues to invest in R&D and acquisitions to drive growth.
Factors Affecting Sun Pharma Share Price in 2025:
- Strong Global Presence: Expanding in the US and emerging markets.
- R&D Investments: Innovation in specialty drugs and biosimilars.
- Regulatory Approvals: Key drug launches in major markets.
- Revenue Growth: Strong financials and increasing sales.
- Partnerships & Acquisitions: Expanding product portfolio through strategic deals.
FAQs About Sun Pharma
Is Sun Pharma a good stock for 2025?
Yes, with a strong global footprint, consistent revenue growth, and a focus on specialty medicines, Sun Pharma remains a solid investment option.
What are Sun Pharma’s key business segments?
The company operates in branded generics, US generics, specialty drugs, and APIs.
Why is Sun Pharma important in the pharmaceutical industry?
Sun Pharma is a leader in generic and specialty medicines, providing affordable healthcare solutions worldwide.
This article provides a detailed analysis of Sun Pharma’s share price target, fundamentals, and expected performance for 2025.
